DnB Asset Management
BIVV

DnB Asset Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

DnB Asset Management’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-177,001
Closed -$9.54M – 631
2017
Q4 		$9.54M Buy
177,001
+44,551
+34% +$2.44M 0.12% 131
2017
Q3 		$7.56M Buy
132,450
+52,300
+65% +$3.06M 0.1% 149
2017
Q2 		$4.82M Buy
80,150
+14,100
+21% +$803K 0.07% 196
2017
Q1 		$3.6M Buy
+66,050
New +$3.25M 0.06% 224

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

DnB Asset Management's BIVV Position: Q1 2018 in Review

DnB Asset Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 177,001 shares — an estimated $9.54M sold.

DnB Asset Management first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $9.54M in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • DnB Asset Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • DnB Asset Management sold 177,001 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $9.54M.
  • DnB Asset Management first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • DnB Asset Management's Bioverativ Inc. Common Stock position peaked at $9.54M in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on DnB Asset Management's 13F filing for Q1 2018, filed 11 Apr 2018.